Artículos por temáticas

Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies

Dolin HH, Zhou B, Maitta RW.

Front Biosci (Landmark Ed). 2025 Jul 7;30(7):27178. doi: 10.31083/FBL27178.

Cell Type-Specific Studies of Human Tissue for Investigation of the Molecular Cell Biology of Late-Onset Neurodegenerative Disease

Mätlik K, Pressl C, Heintz N.

Annu Rev Neurosci. 2025 Jul;48(1):277-295. doi: 10.1146/annurev-neuro-112723-025516. Epub 2025 Mar 18.

Link between Parkinson's disease and melanoma: insights into the influence of the PARK gene family

Wu J, Xiong H, Chen J, Yang D, Li Y, Wang J, Chen J, Zhang R, Zhang R, Li X, Li F, Zhang R, Yang Z.

Front Oncol. 2025 Aug 11;15:1506744. doi: 10.3389/fonc.2025.1506744. eCollection 2025.

Revamping Parkinson's disease therapy using PLGA-based drug delivery systems

Lababidi JM, Azzazy HME.

NPJ Parkinsons Dis. 2025 Aug 20;11(1):248. doi: 10.1038/s41531-025-01081-1.

Hot Topics and Frontiers of Resting-State fMRI in Parkinson's Disease: Research Trends and Paradigm Shifts From a Bibliometric Perspective

Jin Y, Fu J, Guan X, Guo T, Xu X.

Parkinsons Dis. 2025 Aug 7;2025:6870215. doi: 10.1155/padi/6870215. eCollection 2025.

Unveiling Exosome Potential: Transforming Treatments for Neurodegeneration

Tiwari A, Singh B, Singh GK, Meena J, Agrawal AK, Kumar S, Modi G.

ACS Appl Bio Mater. 2025 Jul 21;8(7):5406-5423. doi: 10.1021/acsabm.5c00096. Epub 2025 Jun 23.

The Cognitive Cost of Motor Control: A Systematic Review and Meta-Analysis of Parkinson's Disease Treatments and Financial Decision-Making

Kandylaki N, Patrikelis P, Konitsiotis S, Messinis L, Folia V.

Healthcare (Basel). 2025 Jul 29;13(15):1850. doi: 10.3390/healthcare13151850.

Soil to Synapse: Molecular Insights into the Neurotoxicity of Common Gardening Chemicals in Alzheimer's and Parkinson's Disease

Sharma N, An SSA.

Int J Mol Sci. 2025 Jul 4;26(13):6468. doi: 10.3390/ijms26136468.

Multivariate Associations Between Neurophysiological Activity and Sensory Motor Cortical Morphometry in Parkinson's Disease

Mirpour K, Alijanpourotaghsara A, Pouratian N.

bioRxiv [Preprint]. 2025 Jul 31:2025.07.28.667342. doi: 10.1101/2025.07.28.667342.

Clinical efficacy of GLP-1 receptor agonists in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

Zhang Y, Wang C, Wang Y, Wang T.

J Neurol. 2025 Aug 4;272(9):555. doi: 10.1007/s00415-025-13301-y.

Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?

Dalla Verde C, Jayanti S, El Khobar K, Stanford JA, Tiribelli C, Gazzin S.

Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.

Acupuncture for Parkinson's Disease: A Narrative Review of Clinical Efficacy and Mechanistic Insights

Yu N, Sun D, Ma L, Han Q, Song R, Wang Y.

Neuropsychiatr Dis Treat. 2025 Aug 22;21:1731-1750. doi: 10.2147/NDT.S532027. eCollection 2025.

Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology

Koros C, Fiske B, Stefanis L.

J Parkinsons Dis. 2025 Jun 30:1877718X251354935. doi: 10.1177/1877718X251354935. Online ahead of print.

Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy

O'Sullivan SS, Massey LA, Williams DR, Revesz T, Lees A, Holton J.

BMJ Case Rep. 2025 Aug 9;2009:bcr0820080774. doi: 10.1136/bcr.08.2008.0774.

Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging

Sen MK, Dunville K, Miles N, Newbery M, Ng NS, Ooi L.

Front Cell Neurosci. 2025 Jul 15;19:1650938. doi: 10.3389/fncel.2025.1650938. eCollection 2025.